Global Placental Stem Cell Therapy for Neurological Disorders Market Growth (Status and Outlook) 2025-2031

The global Placental Stem Cell Therapy for Neurological Disorders market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.

The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.

Key Features

This Insight Report provides a comprehensive analysis of the global Placental Stem Cell Therapy for Neurological Disorders landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

Segmentation by Type

• Allogeneic Placental Stem Cell Therapy
• Autologous Placental Stem Cell Therapy

Segmentation by Application

• Hospitals and Specialist Clinics
• Clinical Research Institute

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage

• Mesoblast
• Pleurite Therapeutic
• Athersys
• Cordlife India
• Life Cell
• Cryo-Cell
• CBR Systems
• ReNeuron Group
• Cynata
• Celularity
• Americord Registry
• ReeLabs

Key Questions Addressed in this Report

Evaluation of the key market trends, drivers, and affecting factors shaping the global outlook for Placental Stem Cell Therapy for Neurological Disorders.